BamSEC and AlphaSense Join Forces
Learn More

Vidara Therapeutics International Public Ltd Co

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.17
from S-4 7 pages Consulting Agreement
12/34/56
EX-10.16
from S-4 16 pages Indemnification Agreement
12/34/56
EX-10.15
from S-4 11 pages Dated the 16th Day of April 2012 Benton Property Holding Limited (In Receivership) (1) and Jim Hamilton (2) and Vidara Therapeutics (3) Licence Agreement Re: Unit Nos. 202 and 203 Second Floor Adelaide Chambers Peter Street Dublin 8 Eversheds O’donnell Sweeney Solicitors One Earlsfort Centre Earlsfort Terrace Dublin 2
12/34/56
EX-10.14
from S-4 49 pages Lease by and Between Hub Properties Ga LLC, as Landlord and Vidara Therapeutics Inc. (De), as Tenant With Respect to Holcomb Woods Business Park Roswell, Georgia
12/34/56
EX-10.13
from S-4 10 pages Revenue Adjustment Agreement by and Between Intermune Pharmaceuticals, Inc. and Connetics Corporation June 27, 2000 Revenue Adjustment Agreement
12/34/56
EX-10.12
from S-4 20 pages Assignment and Option Agreement by and Between Intermune Pharmaceuticals, Inc. and Connetics Corporation June 23, 2000 (Superseding and Replacing the Amended and Restated Exclusive Sublicense Agreement of April 27, 1999) Assignment and Option Agreement
12/34/56
EX-10.11
from S-4 4 pages Seventh Amendment to License Agreement for Interferon Gamma
12/34/56
EX-10.10
from S-4 3 pages Amendment No. 6 to the License Agreement for Interferon Gamma
12/34/56
EX-10.9
from S-4 1 page January 25, 2001 Ms. Anna Hall Director of Business Development Genentech, Inc. 1 Dna Way South San Francisco Ca 94080-4990 Re: Amendment No. 5 to the Intermune/Genentech License Agreement Dear Ms. Hall
12/34/56
EX-10.8
from S-4 2 pages Consent to Assignment Agreement Between Connetics and Intermune Pharmaceuticals, Inc. June 23, 2000
12/34/56
EX-10.7
from S-4 14 pages Amendment No. Three to License Agreement
12/34/56
EX-10.6
from S-4 8 pages Amendment No. Two to License Agreement
12/34/56
EX-10.5
from S-4 2 pages Amendment No. One to License Agreement
12/34/56
EX-10.4
from S-4 63 pages License Agreement for Interferon Gamma
12/34/56
EX-10.3
from S-4 41 pages Consolidated Supply Agreement
12/34/56
EX-10.2
from S-4 3 pages Amendment to Asset Purchase Agreement
12/34/56
EX-10.1
from S-4 58 pages Asset Purchase Agreement by and Among Vidara Therapeutics International Limited (As Purchaser), Vidara Therapeutics Holdings LLC (As Parent), Vidara Therapeutics Research Limited (As Opco) and Intermune, Inc. (As Seller) May 17, 2012
12/34/56